About
Antibodies, peptides and small molecules
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibody
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
3,253
By Phase
PHASE2: 2PHASE3: 1EARLY_PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05879432Lead Sponsor
LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
PHASE2Recruiting
240 participants
Started: Mar 8, 2024 · Completed: Nov 30, 2026
NCT04402957Lead Sponsor
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
PHASE2Completed
61 participants
Started: Oct 14, 2020 · Completed: Jun 2, 2022
NCT04330690Collaborator
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
PHASE3Unknown
2,900 participants
Started: Mar 18, 2020 · Completed: May 18, 2024
NCT03772678Lead Sponsor
A Phase I Study to Evaluate LSALT Peptide
EARLY_PHASE1Completed
52 participants
Started: Jun 27, 2019 · Completed: Mar 31, 2020
Locations (1)
Headquarters
Toronto, ON, Canada
Map
Loading map...